Lakeshore Biopharma (LSB) Competitors $2.72 +0.37 (+15.74%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends LSB vs. CABA, IGMS, MIST, CRDL, JSPR, OSTX, COYA, HLVX, MNOV, and XFORShould you be buying Lakeshore Biopharma stock or one of its competitors? The main competitors of Lakeshore Biopharma include Cabaletta Bio (CABA), IGM Biosciences (IGMS), Milestone Pharmaceuticals (MIST), Cardiol Therapeutics (CRDL), Jasper Therapeutics (JSPR), OS Therapies (OSTX), Coya Therapeutics (COYA), HilleVax (HLVX), MediciNova (MNOV), and X4 Pharmaceuticals (XFOR). These companies are all part of the "pharmaceutical products" industry. Lakeshore Biopharma vs. Cabaletta Bio IGM Biosciences Milestone Pharmaceuticals Cardiol Therapeutics Jasper Therapeutics OS Therapies Coya Therapeutics HilleVax MediciNova X4 Pharmaceuticals Cabaletta Bio (NASDAQ:CABA) and Lakeshore Biopharma (NASDAQ:LSB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment. Do institutionals & insiders have more ownership in CABA or LSB? 52.6% of Lakeshore Biopharma shares are owned by institutional investors. 9.9% of Cabaletta Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in CABA or LSB? Cabaletta Bio received 90 more outperform votes than Lakeshore Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformCabaletta BioOutperform Votes9072.00% Underperform Votes3528.00% Lakeshore BiopharmaN/AN/A Which has better valuation & earnings, CABA or LSB? Lakeshore Biopharma has higher revenue and earnings than Cabaletta Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCabaletta BioN/AN/A-$67.68M-$2.15-1.27Lakeshore Biopharma$80.82M0.31-$61.09MN/AN/A Is CABA or LSB more profitable? Lakeshore Biopharma's return on equity of 0.00% beat Cabaletta Bio's return on equity.Company Net Margins Return on Equity Return on Assets Cabaletta BioN/A -50.10% -45.49% Lakeshore Biopharma N/A N/A N/A Does the media refer more to CABA or LSB? In the previous week, Cabaletta Bio had 11 more articles in the media than Lakeshore Biopharma. MarketBeat recorded 11 mentions for Cabaletta Bio and 0 mentions for Lakeshore Biopharma. Lakeshore Biopharma's average media sentiment score of 1.00 beat Cabaletta Bio's score of 0.18 indicating that Lakeshore Biopharma is being referred to more favorably in the news media. Company Overall Sentiment Cabaletta Bio Neutral Lakeshore Biopharma Positive Do analysts recommend CABA or LSB? Cabaletta Bio currently has a consensus target price of $24.38, suggesting a potential upside of 789.60%. Given Cabaletta Bio's stronger consensus rating and higher probable upside, equities analysts plainly believe Cabaletta Bio is more favorable than Lakeshore Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cabaletta Bio 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00Lakeshore Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, CABA or LSB? Cabaletta Bio has a beta of 2.46, suggesting that its share price is 146% more volatile than the S&P 500. Comparatively, Lakeshore Biopharma has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. SummaryCabaletta Bio beats Lakeshore Biopharma on 8 of the 14 factors compared between the two stocks. Get Lakeshore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LSB vs. The Competition Export to ExcelMetricLakeshore BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.32M$6.22B$5.21B$9.14BDividend YieldN/A2.94%5.13%4.02%P/E RatioN/A9.9189.4217.36Price / Sales0.31309.211,240.0477.11Price / CashN/A61.4443.7535.97Price / Book0.316.055.314.79Net Income-$61.09M$154.90M$122.54M$225.00M7 Day Performance-1.09%1.35%1.42%2.37%1 Month Performance-8.11%0.41%2.51%4.40%1 Year PerformanceN/A3.08%25.29%20.10% Lakeshore Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LSBLakeshore Biopharma1.2618 of 5 stars$2.72+15.7%N/AN/A$25.32M$80.82M0.00773Upcoming EarningsPositive NewsGap UpCABACabaletta Bio3.0473 of 5 stars$2.16+3.8%$24.38+1,028.5%-85.9%$105.57MN/A-1.0050Analyst ForecastIGMSIGM Biosciences4.6929 of 5 stars$1.77-15.3%$5.50+210.7%-83.2%$105.25M$2.92M-0.49190MISTMilestone Pharmaceuticals2.3888 of 5 stars$1.97-5.3%$13.00+559.9%+41.4%$105.06M$1M-2.4330CRDLCardiol Therapeutics1.6945 of 5 stars$1.27-0.8%$8.75+589.0%+13.1%$103.76M$60,000.00-3.2620Positive NewsJSPRJasper Therapeutics2.8699 of 5 stars$6.69-5.1%$67.75+912.7%-50.0%$100.36MN/A-1.4120Short Interest ↑OSTXOS Therapies2.2311 of 5 stars$4.65-6.4%$8.00+72.0%N/A$100.13MN/A0.00N/AInsider TradeCOYACoya Therapeutics2.5198 of 5 stars$5.97+3.5%$16.25+172.2%-9.9%$99.74M$9.55M-9.186Short Interest ↑Positive NewsHLVXHilleVax2.4719 of 5 stars$2.00-2.4%$3.00+50.0%-87.2%$99.61MN/A-0.6520Gap UpMNOVMediciNova1.3987 of 5 stars$1.99+1.5%$9.00+352.3%+22.0%$97.60M$1M-9.4810Analyst ForecastNews CoveragePositive NewsXFORX4 Pharmaceuticals4.1829 of 5 stars$0.57-0.8%$3.50+519.1%-32.4%$96.41M$1.12M-6.2880Gap UpHigh Trading Volume Related Companies and Tools Related Companies Cabaletta Bio Competitors IGM Biosciences Competitors Milestone Pharmaceuticals Competitors Cardiol Therapeutics Competitors Jasper Therapeutics Competitors OS Therapies Competitors Coya Therapeutics Competitors HilleVax Competitors MediciNova Competitors X4 Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LSB) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lakeshore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lakeshore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LSB Stock Alerts